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A B S T R A C T
The aim of this study was to determine the expression intensity of c-erbB-2 antigen in
oral lichen planus and erosive form of oral lichen in 30 patients, and to compare the ob-
tained results with the inflammation intensity i.e. hyperkeratosis. The examination of
expression intensity of c-erbB-2 antigen was conducted through immunohistochemical
analysis by APAAP method. Obtained reaction of examined tissue antigen was positive
in individual or in group cells of spinous epithelium layer and mosaically expressed.
The reaction was negative in basal cell epithelium layer. Strong intensity reaction was
observed in intercellular bridges of spinous cells layer. In control group, the reaction
was of uniform strong intensity in all epithelium layers. The reaction was not dependent
on the inflammation intensity in lesions but it was positively correlated with their de-
gree of hyperkeratosis. Changed expression of c-erbB-2 antigen in OLR lesions reveals
the possibility of potential malignant transformation of these lesions.
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Introduction
In recent years the results of various
studies point to premalignant potential of
oral lichen lesions which may cause po-
tential inception of oral squamous carci-
noma (OSCC)1–4. According to the results
of published studies the frequency of ma-
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lignant transformation i.e. frequency of
oral lichen lesions transformation in
OSCC varies, ranging from 0.3–10%5–9.
In some clinical forms of oral lichen ru-
ber, like atrophic, erosive and ulcerous le-
sions, more frequent inception and devel-
opment of OSCC has been observed9–11.
Proto-oncogene c-erbB-2 located on
chromosome 17 at band q21 encodes the
synthesis of phosphoglycoprotein recep-
tor p185erbB2 (p185HER-2/neu), which has ty-
rosine kinase activity. c-erbB-2 receptor
can be found in many tissue cells12,13.
Excessive expression of c-erbB-2 onco-
gene is present in 20%–25% cases of pri-
mary lung tumors and ovaries tumors14,
19%–44% cases of urinary bladder carci-
noma15, certain tumors of salivary glands,
like sialocarcinoma, pleomorphe adenoma
and mucoepidermoid carcinoma16,17, and
in OSCC lesions developed from OLR18–20.
This paper examined the modified tis-
sue expression of c-erbB-2 antigen in
ORL lesions, as important indicator of
the prognosis and course of the disease in
relation with specific clinical forms of oral
lichen ruber, clinical intensity of the in-
flammation of oral mucosa membrane




This study included 30 patients with
oral lichen ruber (OLR), 15 patients with
clinical manifestations of lichen ruber
planus (LRP) and 15 patients with clini-
cal manifestations of erosive lichen ruber
(LRE). Average age of the patients with
oral lichen was 48.112.7 years. Control
group included 15 patients diagnosed
with homogenous oral leukoplakia (OL).
Average age of the patients with oral leu-
koplakia was 44.8712.77 years.
The investigation was carried out
through the clinical diagnosis and deter-
mination of clinical OLR forms and clini-
cal diagnosis of OL21,22.
Clinical status of OLR and OL was
evaluated through the clinical parame-
ters of the disease: inflammation graded
as 0 (no visible inflammatory reaction),
grade 1 (barely visible inflammatory re-
action with local reddening of mucous
membrane and small affected area), gra-
de 2 (inflammatory reaction of medium
intensity ranging between grade 1 and
grade 3) and grade 3 (distinctly reddish
and extended inflammatory reaction of
high intensity; affected area of oral mu-
cous membrane is wider than in hyper-
keratosis lesion of OLR); hyperkeratosis
graded as 0 (no visible keratosis), grade 1
(mild, whitish-gray hyperkeratosis bare-
ly visible on oral mucous membrane; af-
fected area is less than 5 mm2), grade 2
(the color of hyperkeratosis changes to
whitish-gray with affected area between
5–10 mm2) and grade 3 (white hyper-
keratosis with affected area bigger than
10 mm)23.
The diagnosis of oral lichen ruber and
oral leukoplakia determined on a basis of
described clinical oral tests and parame-
ters were confirmed in all patients through
the pathohistologic diagnosis21,24.
Biopsy samples
Biopsy samples were collected from
the pathologically changed oral mucosa
membrane, from the border between
healthy and diseased tissue, after the ad-
ministration of 1 ml of local anesthetic so-
lution (3% Mepivastein, ESPE, Germa-
ny).
Before the biopsy, sampling the pa-
tients with OLR and OL did not go trough
adequate systemic or local therapy.
Immunohistochemical analysis
of biopsy samples
Tissue samples were fixated in buf-
fered 4% paraformaldehyde for 24 h, em-
bedded in paraffin and sectioned with
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cryomicrotome to 4 nm thick slices. After
deparaffination and rehydration, tissue
slices were routinely processed and stai-
ned with hematoxylin-eosin and mounted
on a slide with Canada balsam.
For the purpose of immunohistoche-
mical analysis antigen demasking was
performed by heating tissues sections in
a microwave oven (MOULINEX) 3x5' at
800 W in citric acid buffer (pH 6.0). Then
the sections were rinsed several times in
TRIS buffer (pH 7.6) and processed with
APAAP method (Alkaline Phosphatase-
Anti-Alkaline Phosphatase Complex) by
incubation with BCIP/NBT (Alkaline
Phosphatase chromogen kit – DAKO)
substrate for 1 hour at the room tempera-
ture. Monoclonal mouse antibody anti-
human c-erbB-2 (DAKO) was tested in
optimal dilution of 1:50. The final product
of the reaction was visualized as dark
blue precipitate located on cellular mem-
brane.
The intensity of immunohistochemical
reaction of tissue antigen c-erbB-2 ex-
pression in samples was evaluated semi
quantitatively and marked as a reaction
of negative intensity (–), low positive in-
tensity (+), moderate positive intensity
(++) and high positive intensity (+++).
Statistical data processing
The results were statistically analy-
zed using nonparametric 2 test and the
Spearman rank correlation method. The
results were considered statistically im-
portant if the level of importance was 5%
or lower (p<0.05). Statistical program
STATISTICA for Windows, Release 5.5 H
('99 Edition) was used during the analy-
sis of the results.
Results
Obtained expression intensity values
of this antigen, i.e. the share of individual
tissue expression intensity of c-erbB-2
antigen in biopsy samples of OLR and OL
lesions are shown in Figure 1.
Statistically important lower intensity
of c-erbB-2 antigen expression was ob-
served when compared with the intensity
of its expression in OL samples (2=
23.4611; p<0.0001).
Immunohistochemical analysis of bi-
opsy samples of OLR lesions showed a
polymorph membranous reaction of
c-erbB-2 antigen expression in the epithe-
lial cells, especially expressed in the to-
pography and the intensity of the reac-
tion itself with accentuated mosaic
pattern (Figure 2), that was expressed
mostly in spinous cells layer but negative
in superficial cells layer. The reaction
was intensely positive in interepithelial
bridges of the spinous cell layer (Figure
3). Opposite to positive reaction in spi-
nous cell layer, the reaction was negative
in basal cell layer.
Analysis of biopsy samples of OL
showed the membranous-type reaction,
exclusively uniform and strong in spinous
and basal cell layers (Figure 4).
Expression intensity of that antigen
was equal in biopsy samples of various
clinical forms of LRE and LRP (2=0.254;
p=0.8807).
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Fig. 1. The proportion of the expression inten-
sity of tissue antigen c-erbB-2 in oral lichen ru-
ber lesions (OLR; N=30) and oral leukoplakia
lesions (OL; N=15).
The expression intensity of c-erbB-2
tissue antigen with the intensity of in-
flammation in OLR and OL lesions is
shown in Tables 1 and 2.
Relation between inflammation inten-
sity and the expression intensity of
c-erbB-2 antigen in OLR and OL lesions
was not evidenced (=–0.266; p=0.077).
The comparison between expression
intensity of c-erbB-2 tissue antigen and
the intensity of hyperkeratosis in OLR
and OL lesions is shown in Table 3 and 4.
Hyperkeratosis intensity in OLR and
OL lesions was positively correlated with
the expression intensity of c-erbB-2 tis-
sue antigen (=0.687; p<0.0001).
Discussion
The perception that the excessive ex-
pression of c-erbB-2 antigen exists in ma-
lignantly transformed cells revealed the
necessity to identify this antigen as a sta-
tus indicator of malignantly changed le-
sions. Strong expression of c-erbB-2 onco-
gene was observed in many neoplasms
where its expression was positively corre-
lated with their invasiveness and their
ability to metastasize in other tissues.
The results of this study revealed dif-
ferent expression of c-erbB-2 than expec-
ted.
Tissue expression of c-erbB-2 antigen
in OLR lesions showed low reaction in-
tensity compared to the distinctly strong
reaction intensity in OL lesions. There
was no difference in the c-erbB-2 antigen
expression intensity in erosive and in pla-
nus lichen. The relation between the in-
flammation intensity and the expression
intensity of c-erbB-2 protein in OLR and
458
A. Pirki} et al.: C-erb-B2 Oncogen in Oral Lichen Ruber, Coll. Antropol. 28 (2004) 1: 455–461
Fig. 3. Oral lichen ruber (OLR). Intensified im-
munohistochemical reaction expressed in inter-
epithelial bridges of the spinous cell layer
(APAAP x400).
Fig. 4. Oral leukoplakia (OL). Intensified im-
munohistochemical reaction of equally strong
intensity in the basal cell and in spinous cell
layers (APAAP x200).
Fig. 2. Oral lichen ruber (OLR). Mosaicism of
immunohistochemical reaction expressed in
the spinous cell layer (APAAP x200).
OL lesions was not evidenced. On the
other hand, positive correlation between
expression intensity of c-erbB-2 protein
and the intensity grade of hyperkeratosis
in lesions was observed.
Observed lower expression intensity
of c-erbB-2 antigen in OLR lesions is the
most interesting result of this study. Sim-
ilar results were obtained by other au-
thors18–20.
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TABLE 3
THE PROPORTIONS OF EXPRESSION INTENSITY OF TISSUE ANTIGEN C-ERBB-2 RELATED
WITH THE DEGREE OF HYPERKERATOSIS IN ORAL LICHEN RUBER LESIONS (OLR; N=30)
Expression intensity
of c-erbB-2 antigen
Hyperkeratosis degree in OLR lesions % (N)
0 1 2 3
+ 0 13.3 (4) 16.7 (5) 0
++ 0 0 36.7 (11) 10.0 (3)
+++ 0 0 0 23.3 (7)
+ = low positive intensity, ++ = moderate positive intensity, +++ = high positive intensity
TABLE 4
THE PROPORTIONS OF EXPRESSION INTENSITY OF TISSUE ANTIGEN RELATED WITH
THE DEGREE OF HYPERKERATOSIS IN ORAL LEUKOPLAKIA LESIONS (OL; N=15)
Expression intensity
of c-erbB-2 antigen
Inflammation grade in OL lesions % (N)
0 1 2 3
+ / ++ 0 0 0 0
+++ 0 0 40.0 (6) 60.0 (9)
+ = low positive intensity, ++ = moderate positive intensity, +++ = high positive intensity
TABLE 2
THE PROPORTIONS OF EXPRESSION INTENSITY OF TISSUE ANTIGEN C-ERBB-2 RELATED
WITH THE INFLAMMATION GRADE IN ORAL LEUKOPLAKIA LESIONS (OL; N=15)
Expression intensity
of c-erbB-2 antigen
Inflammation grade in OL lesions % (N)
0 1 2 3
+ / ++ 0 0 0 0
+++ 46.7 (7) 26.7 (4) 26.7 (4) 0
+ = low positive intensity, ++ = moderate positive intensity, +++ = high positive intensity
TABLE 1
THE PROPORTIONS OF EXPRESSION INTENSITY OF TISSUE ANTIGEN C-ERBB-2 RELATED
WITH THE INFLAMMATION GRADE IN ORAL LICHEN RUBER LESIONS (OLR; N=30)
Expression intensity
of c-erbB-2 antigen
Inflammation grade in OLR lesions % (N)
0 1 2 3
+ 0 0 26.7 (8) 3.3 (1)
++ 0 0 13.3 (4) 33.3 (10)
+++ 0 0 0 23.3 (7)
+ = low positive intensity, ++ = moderate positive intensity, +++ = high positive intensity
The results of immunohistochemical
reaction obtained polymorphy of the
membranous c-erbB-2 antigen reaction
according to its intensity and topography,
with the accentuated reaction in spinous
cells layer but negative in basal cells
layer. Membranous reaction of c-erbB-2
protein could be seen as specific because
the antibodies to this antigen recognize
its extracellular part. Intense positive re-
action in intercellular bridges of the oral
epithelium was also observed, making
the precedent in literature. The cause for
such polymorphism of tissue expression
of c-erbB-2 protein in OLR lesions should
be looked for in pathogenetic mechanism
of appearance and progression of the dis-
ease, including the immunological back-
ground and the important role of kera-
tinocytes as immunocompetent cells.
The results of recent published stud-
ies reveal that keratinocytes in OLR le-
sions secret cytokines IL-6 (interleukin-
6) and TNF- (tumor necrosis factor-).
The very characteristic morphologic le-
sion of basal cell layer of the oral epithe-
lium in OLR lesions is result of lympho-
cyte infiltration and mutual interaction
of CD8 lymphocytes and keratinocytes18.
Released cytokines may take over the
role of autocrine growth factors and in-
duce their proliferation18.
During the explanation of obtained re-
sults, we cannot ignore the fact that
c-erbB-2 protein exists in certain tissues
during the embryonic development as
well as in the salivary glands epithelium
and colonic epithelium of the adults12.
The results of the some studies revealed
c-erbB-2 positive immunohistochemical
reaction in healthy oral mucosa18–20.
Comparison between c-erbB-2 protein
expressions in specific oral mucosa le-
sions revealed its lower expression inten-
sity, e.g. the loss of expression in OLR le-
sions as well as in lesions of OSCC which
were developed from OLR lesions when
compared to the expression in OSCC not
followed the oral lichen18–20. Similar re-
sults were obtained in this study where
lower expression intensity of c-erbB-2 an-
tigen in oral lichen ruber lesion was ob-
served.
Lower expression intensity of c-erbB-2
antigen in OLR lesions reveals its chan-
ged expression in dysplastic oral epithe-
lia, which was confirmed by other au-
thors19,20. Cellular immunoreactions play
a key role in pathogenetic mechanism of
OLR development and precede dysplastic
changes20. Accumulation of mononuclear
infiltrate with keratinocytes interaction
induces the release of multitude of cyto-
kines that may affect the c-erbB-2 trans-
membranous protein expression. It is a
well-known fact that the activity of IFN-
(interferon-gamma) induces an array of
changes in cellular surface that may af-
fect the expression of cellular receptors as
well as the oncogene expression12,13.
Conclusion
This study showed changed expres-
sion of tissue antigen c-erbB-2 in OLR le-
sions, manifested as a membranous-type
reaction, which polymorphy varied accor-
ding to the intensity and topography. De-
scribed low expression reaction of tissue
antigen c-erbB-2 in basal and parabasal
cell layer in OLR lesions combined with
strong intensity reaction in intercellular
bridges of spinous cell layer can be an
early sign of the tissue transformation.
Weakened or negative immunohistoche-
mical reaction in oral lichen lesions, op-
posite to the stronger reaction in OL le-
sions, reveals the existence of some
internal provoking signal that can induce
the malignant transformation of OLR le-
sions.
460
A. Pirki} et al.: C-erb-B2 Oncogen in Oral Lichen Ruber, Coll. Antropol. 28 (2004) 1: 455–461
R E F E R E N C E S
1. SILVERMAN, S. Jr., S. BAHR, Am. J. Dent., 10
(1997) 259. — 2. VAN DER MEIJ, E. H., K. SCHEP-
MAN, Oral. Surg. Oral Med. Oral Pathol., 88 (1999)
307. — 3. GARCIA-POLA, M. J., J. M. GARCIA-
MARTIN, M. GONZALES, Oral Dis., 5 (1999) 259. —
4. HIETANEN, J., M. R. PASSONEN, M. KUHLE-
FELT, Oral Oncol., 35 (1999) 278. — 5. BERNARD,
N. A., C. SCULLY, J. W. EVERSON, S. CUNNIN-
GHAM, S. R. PORTER, J. Oral Pathol. Med., 22
(1993) 421. — 6. BIO^INA-LUKENDA, D., A. CE-
KIC-ARAMBA[IN, K. JORGI]-SRDJAK, Coll. An-
tropol., 22 (1998) 83. — 7. EISENBERG, E., D. J.
KRUTCHKOFF, Oral Surg. Oral Med. Oral Pathol.,
73 (1992) 699. — 8. HOLMSTRUP, P., Oral Surg. Oral
Med. Oral Pathol., 73 (1992) 704. — 9. BIO^INA-LU-
KENDA, D., Acta Stomatol. Croat., 36 (2002) 451. —
10. SILVERMAN, S. Jr., F. LOZADA-NUR, C. MI-
GLIORETI, Oral. Surg. Oral Med. Oral Pathol., 59
(1995) 360. — 11.SILVERMAN, S. Jr., M. GORSKY, F.
LOZADA-NUR, K. GIANNOTI, Oral Surg. Oral Med.
Oral Pathol., 72 (1991) 665. — 12. SCHECHTER, A.
L., D. F. STERN, L. VAIDYANATHAN, S. J. DE-
CKER, J. A. DREBIN, M. I. GREENE, R. A. WEIN-
BERG, Nature, 312 (1984) 513. — 13. OCHAREN-
RAT, P., P. H. RHYS-EVANS, H. MODJTAHEDI, S. A.
ECCLES, Oral Oncol., 38 (2002) 627. — 14. HORI-
GUCHI, J., Y. ILNO, H. TAKEI, Oncology, 1 (1994)
47. — 15. LIPPONEN, P. K., Pathobiology, 61 (1993)
178. — 16. DARDICK, J. R., L. E. BIREK, J. Oral Me-
dical Pathol., 23 (1994) 226. — 17. KRECECKI, T., M.
JELEN, M. ZALESSKA-KRECICKA, Acta Otoralyn-
gol. (Stockh)., 119 (1999) 392. — 18. KILPI, A., A.
RICH, Y. T. KONTTINEN, P. READE, Br. J. Derma-
tol., 133 (1995) 847. — 19.KILPI, A., A. M. RICH, Y. T.
KONTTINEN, P. C. READE, Eur. J. Oral Sci., 104
(1996) 278. — 20. KILPI, A., A. M. RICH, P. C. REA-
DE, Y. T. KONTTINEN, Austral. Dental J., 41 (1996)
87. — 21. WHO, Oral Surg. Oral Med. Oral Pathol.,
46 (1978) 213. — 22. ANDREASEN, J. O., Oral Surg.
Oral Med. Oral Pathol., 25 (1968) 31. — 23. DOBRE-
NI], M, Oralne bolesti: Dijagnostika i terapija. (JU-
MENA, Zagreb, 1987). — 24. ANDREASEN, J. O.,
Oral Surg. Oral Med. Oral Pathol., 25 (1968) 158.
A. Pirki}
Department of Clinical Pathology »Ljudevit Jurak«, University Hospital
»Sestre milosrdnice«, Vinogradska c. 29, 10000 Zagreb, Croatia
PROMJENE U TKIVNOJ EKSPRESIJI C-ERB-2 ONKOGENA
U ORALNOM LICHEN RUBERU
S A @ E T A K
U radu je istra`en intenzitet izra`ajnosti c-erbB-2 antigena u oralnom lichen ruber
planus (LRP) i u lichen ruber erosivus (LRE) u 30 bolesnika s oralnim lichenom. Rezul-
tati su uspore|eni s klini~kim stupnjevima upale i hiperkeratoze. Izra`ajnost antigena
c-erbB-2 istra`ena je imunohistokemijskom APAAP metodom. Tkivna reakcija bila je
mozai~kog tipa i pozitivna u pojedina~nim stanicama spinoznog sloja oralnog epitela,
dok je u stanicama bazalnog sloja bila negativna. Reakcija jakog intenziteta zapa`ena
je u me|ustani~nim mosti}ima spinoznog sloja. Intenzitet reakcije je bio neovisan o
stupnju upale, ali je pozitivno korelirao sa stupnjem hiperkeratoze. U kontrolnoj grupi
oralne leukoplakije reakcija je bila pozitivnog ishoda u stanicama svih slojeva oralnog
epitela i uniformno jakog intenziteta. Promijenjena tkivna izra`ajnost c-erbB-2 anti-
gena u oralnom lichen ruberu indicira potencijalnu zlo}udnu pretvorbu ove lezije.
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